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Abstract 
 
The aim of this licentiate thesis is to assess by literature the potential exposure of humans to Mycobacterium avium subspecies paratuberculosis 
(MAP) through food and drinking water in Finland and Minnesota, USA and to represent the prevalence (the total number of cases of a disease 
at a specific time) of Johne’s disease and the prevalence and incidence (the number of new cases of a disease during a certain period of time) 
Crohn’s disease in the United States, Minnesota and Finland.  
Johne’s disease (JD), also known as paratuberculosis, is a globally important chronic intestinal disease of cattle and other ruminants such as 
goats and sheep caused by MAP.  
Crohn’s disease (CD) is a chronic intestinal disease of humans. The etiology of CD is unknown but in addition to genetic susceptibility, 
environmental factors have been found to have an impact on the onset of the disease. It has been suggested that MAP could be one of the 
etiologic agents of CD.  
In the United States, JD is more common in dairy cattle than in beef cattle. The apparent cow-level prevalence is 6% and apparent herd-level 
prevalence is 68% in dairy cattle. In Minnesota the apparent prevalence of JD in dairy cattle at the cow-level is 3% and at the herd-level 46%. In 
beef cattle the prevalence at the cow-level is only 0.3% in Minnesota. The prevalence of CD in the United States is 241/100,000 and the annual 
incidence 20/100,000. The prevalence of CD in Minnesota is 222/100,000 and the annual incidence 13/100,000. 
In Finland, JD has been diagnosed in five beef cattle herds since 1992. The disease has not been diagnosed in dairy cattle or sheep or goats in 
Finland. The prevalence of CD in Finland is 124/100,000 and the annual incidence 9/100,000. 
The prevalence of MAP in food and drinking water in Finland has not been studied. Despite this, it is unlikely that people are exposed to MAP 
through drinking water or by eating foods of Finnish origin because the prevalence of JD in Finland is very low. However, exposure to the 
bacterium is possible by eating imported beef and dairy products such as cheese and yogurt. The share of imported foods within these food 
groups is relatively large in Finland. Dairy products and beef are imported for example from Germany and Denmark where the prevalence of JD 
at the herd-level is about 50–80%. 
In the United States the occurrence of MAP in foods and drinking water has been studied quite much. It appears that the bacterium is found in 
foods and drinking water of U.S. origin. Because JD is so common in the United States and Minnesota, it is likely that people are exposed to the 
bacterium in Minnesota even though not all the food eaten is produced in the state. 
It is likely that people in areas of high prevalence of JD are exposed more to MAP than people in areas of low prevalence of JD. Comparing 
subsets of CD patients with high exposure to MAP to healthy controls with and without exposure to MAP could reveal the possible role of MAP 
in the complex etiology of CD. Based on this literature review it can be assumed that in Finland CD is caused by some other environmental 
agent than MAP. This licentiate thesis sets up further research needs to estimate the true human exposure to MAP. 
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Tämän lisensiaatin tutkielman tarkoituksena on arvioida kirjallisuuden avulla ihmisten altistumista Suomessa ja Minnesotan osavaltiossa, 
Yhdysvalloissa Mycobacterium avium subspecies paratuberculosis (MAP) -bakteerille elintarvikkeiden ja juomaveden välityksellä sekä 
raportoida paratuberkuloosin prevalenssi eli vallitsevuus (sairaiden lukumäärä tietyllä hetkellä) ja Crohnin taudin prevalenssi ja insidenssi eli 
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kuten vuohien ja lampaiden krooninen suolistosairaus, jonka aiheuttaa MAP -bakteeri.  
Crohnin tauti puolestaan on ihmisten krooninen suolistosairaus. Crohnin taudin etiologia eli sairauden syy on epäselvä, mutta geneettisen 
alttiuden lisäksi myös ympäristötekijöillä on todettu olevan vaikutusta taudin puhkeamiseen.  On ehdotettu, että MAP saattaisi olla yksi Crohnin 
taudin aiheuttajista.  
Yhdysvalloissa paratuberkuloosi on yleisempi lypsykarjoissa kuin lihakarjoissa. Lypsylehmillä prevalenssi on yksilötasolla 6 % ja tilatasolla   
68 %. Minnesotassa lypsylehmillä paratuberkuloosin prevalenssi on yksilötasolla 3 % ja tilatasolla 46 %, kun taas osavaltion lihanaudoilla 
prevalenssi on ainoastaan 0,3 %. Crohnin taudin prevalenssi on Yhdysvalloissa 241/100.000 ja vuosittainen insidenssi 20/100.000. 
Minnesotassa Crohnin taudin prevalenssi on 222/100.000 ja vuosittainen insidenssi 13/100.000. 
Suomessa paratuberkuloosia on todettu viidellä eri lihakarjatilalla vuoden 1992 jälkeen. Tautia ei ole löydetty lypsykarjoista eikä myöskään 
vuohilla tai lampailla. Crohnin taudin prevalenssi on Suomessa 124/100.000 ja vuosittainen insidenssi 9/100.000. 
Suomessa MAP-bakteerin esiintyvyyttä elintarvikkeissa ja juomavedessä ei ole tutkittu. Siitä huolimatta on epätodennäköistä, että ihmiset 
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naudanlihaa tuodaan Suomeen paljon muun muassa Saksasta ja Tanskasta, missä paratuberkuloosin tilatason prevalenssi on noin 50–80 %. 
Yhdysvalloissa MAP-bakteerin esiintyvyyttä elintarvikkeissa ja juomavedessä on tutkittu kohtalaisesti. Vaikuttaa siltä, että bakteeria esiintyy 
Yhdysvalloissa juomavedessä sekä elintarvikkeissa. Koska paratuberkuloosi on niin yleinen Yhdysvalloissa ja Minnesotassa, on todennäköistä, 
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välityksellä kuin ihmiset alhaisilla prevalenssialueilla. Vertailemalla Crohnin taudin potilaiden osajoukkoja terveisiin kontrolleihin, jotka sekä 
altistuvat, että eivät altistu MAP-bakteerille on mahdollista selvittää MAP-bakteerin mahdollista roolia Crohnin taudin monitahoisessa 
etiologiassa. Tämän kirjallisuuskatsauksen perusteella voidaan olettaa, että Suomessa Crohnin taudin aiheuttaa jokin muu ympäristötekijä kuin 
MAP. Tämä lisensiaatin tutkielma antaa pohjatietoa todellisen MAP-bakteerille altistumisen arvioinnille. 
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ABBREVIATIONS 
 
CD – Crohn’s disease 
cfu – Colony forming units 
ELISA – Enzyme-Linked Immunosorbent Assay 
HTST pasteurization – High temperature short time pasteurization 
IBD – Inflammatory bowel disease 
JD – Johne’s disease 
MAC – Mycobacterium avium-intracellulare complex 
MAP – Mycobacterium avium subspecies paratuberculosis 
MBAH – Minnesota Board of Animal Health 
NACMCF – National Advisory Committee on Microbiological Criteria for Foods 
OR – Odds ratio 
PCR – Polymerase chain reaction 
UC – Ulcerative colitis 
USDA – United States Department of Agriculture 
WHO – The World Health Organization 
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1 INTRODUCTION 
 
Johne’s disease (JD), also known as paratuberculosis is a chronic intestinal disease of 
cattle and other ruminants such as goats and sheep. Mycobacterium avium subspecies 
paratuberculosis (MAP) is the causative agent of JD. Crohn’s disease (CD) is a chronic 
intestinal disease of humans quite similar to JD. The etiology of CD is unknown but 
genetic and environmental factors are thought to play a role in the development of the 
disease. It has been suggested that MAP could be one of the etiologic agents of CD. 
One possible way for humans to be exposed to MAP is through food and drinking 
water, since MAP is shed in milk and feces of infected animals and can thus enter the 
food chain.  
 
If MAP is found to be a causative agent of CD, the occurrence of MAP in foods would 
pose a big public health risk. It would mean that the human exposure to MAP, not only 
through foods but through other sources as well, should be limited. This would be 
challenging since JD is so widespread throughout the world. Proving that MAP is one of 
the etiologic agents of CD would also cause significant changes in the animal husbandry 
including the control of JD in cattle production, cattle import and export and the way 
food is produced. It would also significantly increase the amount of research done in 
these two diseases and may help developing a cure for CD. Researching this possible 
link between JD and CD would thus be crucial. 
 
 
2 AIM OF THE STUDY 
 
The aim of this licentiate thesis is to evaluate the possible link between MAP and CD, 
to report the exposure of humans to MAP through food and drinking water in Finland 
and Minnesota, USA and also to represent the prevalence of JD and the prevalence and 
incidence of CD in these geographical areas. This focus is due to that JD is very 
common in cattle, especially in dairy cattle in Minnesota and really rare in Finland. CD 
on the other hand is common in both areas. 
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The hypothesis is that people are exposed to MAP less in Finland than in Minnesota 
through food and drinking water due to the different prevalence of JD in these areas. 
The exposure of humans to MAP through food and drinking water has not been 
compared geographically like this before. This thesis sets up further research needs to 
estimate the true exposure of humans to MAP in Finland and Minnesota. The possible 
role of MAP in the etiology of CD could be further revealed if subsets of CD patients 
with high exposure to MAP were identified and compared to controls with and without 
exposure to MAP. This kind of research would be a small step towards unraveling the 
etiology of CD and possibly eventually finding a cure for the disease.  
 
 
3 JOHNE’S DISEASE  
 
JD affects a large number of ruminant species including cattle, sheep, goats and deer 
(Cocito et al. 1994). It has also been diagnosed in ruminants such as Rocky Mountain 
bighorn sheep (Ovis canadensis), Rocky Mountain goat (Oreamnos americanus) and 
wild bison (Bison bison athabascae) (Williams & Spraker 1979, Sibley et al. 2007). 
Positive cases among non-ruminant species such as stumptail macaque monkeys 
(Macaca arctoides), fox (Vulpes vulpes), stoat (Mustela erminea), weasel (Mustela 
nivalis), crow (Corvus corone) and rabbit (Oryctolagus cuniculus) have also been found 
(McClure et al. 1987, Beard et al. 2001, Judge et al. 2006). 
 
3.1 Etiology 
JD is caused by Mycobacterium avium subspecies paratuberculosis (MAP), which 
belongs to the genus Mycobacterium (Cocito et al. 1994). There are about 100 members 
in the genus but most of the members are saprophytic bacteria found in the environment 
(Hirsh & Biberstein 2004). Mycobacteria are cytochemically gram-positive but they do 
not stain with the Gram stain because the high lipid and mycolic acid content of their 
cell walls prevent the uptake of the stains (Quinn et al. 2011). The pathogenic members 
of the genus Mycobacterium include bacteria like M. tuberculosis, M. bovis, M. avium 
and M. leprae, which cause chronic granulomatous disease such as tuberculosis in 
humans, bovine tuberculosis, avian tuberculosis and leprosy, respectively (Quinn et al. 
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2011). Although the pathogenic mycobacteria usually have a specific host, they are 
capable of infecting other species as well, e.g. M. bovis can cause tuberculosis in 
humans (Quinn et al. 2011). 
 
3.1.1 Mycobacterium avium subsp. paratuberculosis (MAP) 
MAP is a rod-shaped, acid-fast, obligate aerobe intracellular bacterium which belongs 
to the genus Mycobacterium (Hirsh & Biberstein 2004, Quinn et al. 2011). MAP can be 
classified as a member of Mycobacterium avium complex (MAC) which consists of 
closely related species M. intracellulare and M. avium (Goodfellow & Magee 1998). M. 
avium can be divided into four subspecies M. avium subsp. avium, M. avium subsp. 
paratuberculosis, M. avium subsp. silvaticum and M. avium subsp. hominissuis 
(Springer et al. 1996, Mijs et al. 2002). There are at least two different main strain types 
of MAP; the cattle (C) and sheep (S) strains (Collins et al. 1990). Since these strains are 
not host-specific, another classification has been developed for MAP (type I and type II) 
to avoid confusion with the names, since it is not always evident whether the name 
“sheep” or “cattle” stain refers to the host where the bacterium was isolated or to the 
strain of bacterium in question (Stevenson et al. 2002). Type I is comprised of four 
pigmented ovine isolates of MAP and type II comprises nine isolates from a broad host 
range including humans (Stevenson et al. 2002, Dohmann et al. 2003). The pigmented 
isolates produce yellow or orange pigment which is present in all stages of growth in the 
bacterium (Stevenson et al. 2002). 
 
3.2 Global prevalence 
JD is common throughout the world (Harris & Barletta 2001). However, there are areas 
where the disease is really rare, such as in the eastern regions of Australia and in 
Finland, Sweden, Norway and Iceland (Nyberg et al. 2005, Evira 2008, Nacy & 
Buckley 2008). For example, in Sweden only about 50 positive cases of JD in beef 
cattle have been found since 1993 (Lewerin 2007). In Norway, the disease is endemic in 
goats in some parts of western Norway (Norwegian Veterinary Institute 2014). In cattle, 
only few positive cases have been found since mid-19
th
 century in Norway (Nyberg et 
al. 2005). In Denmark, in contrast to the other Nordic countries, JD is common in dairy 
cattle (Nielsen 2007). At the herd-level, the prevalence is 47% in Denmark (Nielsen 
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2007). In Germany the herd-level prevalence of JD in cattle is over 80% and on cow-
level between 1% and 17% in several states (Bülte et al. 2005). JD was thought to be 
eradicated from Poland in the 1960–70s but in a study made in 2008, the apparent herd-
level seroprevalence of JD in dairy cattle herds was found to be 6% in two districts of 
northeastern Poland (Szteyn & Wiszniewska-Łaszczych 2011). The cow-level 
seroprevalence was 2% (Szteyn & Wiszniewska-Łaszczych 2011). In Brazil, the disease 
occurs sporadically and clinical cases of bovine JD have been found in several states in 
the 21
st
 century (Gomes 2010). 
 
3.3 Clinical signs 
The clinical signs in cattle include diarrhea, weight loss, and in advanced disease 
cachexia and reduction in milk yield (Whitlock & Buergelt 1996). Also “bottle jaw” 
(intermandibular edema) can occur in advanced stages of the disease because of 
hypoproteinemia due to lesions in the intestines (Whitlock & Buergelt 1996). JD has an 
incubation period of two to ten years (Whitlock & Buergelt 1996). In an infected herd, 
most animals do not show any clinical signs and in general, young animals are normally 
asymptomatic (Whitlock & Buergelt 1996). In adult animals the infection might be 
subclinical and it is possible that these animals shed the bacteria in feces (Whitlock & 
Buergelt 1996). An animal with clinical signs can shed billions of bacteria in feces daily 
(Sweeney 1996).  
 
 
In sheep and goats the clinical signs appear earlier than in cattle (Stehman 1996). A 
common clinical sign in sheep and goats is emaciation (Radostits et al. 2007). Shedding 
of the wool in sheep might be possible (Radostits et al. 2007). Diarrhea is not a 
common sign in sheep and goats (Radostits et al. 2007). Depression and dyspnea can 
occur in goats but these signs are not normally evident in sheep (Radostits et al. 2007).  
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3.4 Pathogenesis and pathologic findings 
The ingested bacteria enter the Peyer’s patches in the ileum through cells called M-cells 
(Momotani et al. 1988). Within the Peyer’s patches the bacteria are phagocytized by 
macrophages (Momotani et al. 1988). The bacteria multiply within the macrophages 
and granulomas form to the site of entry (Zurbrick & Czuprynski 1987, Cocito et al. 
1994).  
 
Gross lesions of JD in cattle are normally confined to the distal part of the small 
intestine and associated lymph nodes (Whitlock & Buergelt 1996). The pathologic 
findings in cattle include cachexia, chronic enteritis, chronic intestinal lymphangitis and 
mesenteric and ileocaecal lymphadenopathy (Buergelt et al. 1978). The mucosa of 
ileum seems visibly thickened and corrugated (Buergelt et al. 1978). In histopathology, 
epitheloid macrophages and multinucleate giant cells in the lamina propria and 
submucosa of the infected gut are found (Buergelt et al. 1978). Also microgranulomas 
in the liver can be found (Buergelt et al. 1978). The villi of the mucosa of the small 
intestine often fuse which causes malabsorption of nutrients and can eventually lead to 
emaciation of the animal (Whitlock & Buergelt 1996, Radostitis et al. 2007). 
 
3.5 Transmission 
Calves become infected with MAP by vertical transmission in utero or by orally 
ingesting the bacterium by drinking contaminated milk, colostrum or water or by 
ingesting feces contaminated with the bacterium for example by sucking contaminated 
teats (Lawrence 1956, Merkal et al. 1987, Seitz et al. 1989, Sweeney 1996, Whittington 
et al. 2005). Often the calving pen is contaminated with the bacterium either by the dam 
or by previous occupants and thus provides an easy route of infection (Sweeney 1996). 
The bacterium has also been cultured from the semen and genital organs of infected 
bulls with clinical signs of JD (Larsen et al. 1970).  
 
Young animals are more susceptible to JD than adult animals (Sweeney 1996). Because 
of the long incubation period of the disease, animals infected as adults rarely develop a 
clinical disease because they are normally culled before the appearance of clinical signs 
(Whitlock & Buergelt 1996). Adults may become infected by the fecal-oral route for 
example by eating contaminated feed (Lombard 2011). Also new animals from an 
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infected herd might infect animals without JD (Sweeney 1996). Minor risks of infection 
include purchase of contaminated milk or colostrum and sharing of pastures and water 
sources with animals from infected herds (Lombard 2011). 
 
3.6 Diagnosis, treatment and prevention 
3.6.1 Diagnosis 
Enzyme-linked immunosorbent assay (ELISA) is used to diagnose JD (Yokomizo et al. 
1983). Commercially available ELISA are for example milk and serum ELISA tests 
(Nielsen 2010). The sensitivity of ELISA varies quite much but in general it is low 
(Nielsen & Toft 2008). Sweeney et al. (1995) showed that the sensitivity is only 15%, if 
ELISA is used to detect subclinical animals. The advantage of ELISA is the low cost of 
the test (Nielsen 2010). Also the test can easily be performed on a large number of 
samples and the results are ready quickly (Nielsen 2010).  
 
It was previously thought that an insertion element known as IS900 was specific to 
MAP, and that it could be used for the diagnosis of JD with polymerase chain reaction 
(PCR) (Collins et al. 1989, Green et al. 1989, Vary 1990, Moss et al. 1991). It was later 
noticed that the insertion element is not specific to MAP but it was also occasionally 
found in other Mycobacteria species (Cousins et al. 1999, Englund et al. 2002). Despite 
the possible cross-reaction with IS900-like elements, IS900 is recommended as a target 
gene for MAP especially if complimentary testing is done (Bölske & Herthnek 2010). 
This is based on the thorough validation of the gene as a target gene (Bölske & 
Herthnek 2010). Other ways to diagnose MAP by PCR are for example the detection of 
DNA fragments f57 and hspX (Poupart et al. 1993, Ellingson et al. 1998).  
Besides the extensive use of PCR for detection of MAP, the bacterial culture is still 
used as a confirmatory test to diagnose the disease (Chiodini et al. 1984, Möbius et al. 
2008). By bacterial culture, MAP can be distinguished from other members of MAC 
bacteria by its requirement of mycobactin for growth (Thorel et al. 1990). The 
bacterium can be cultured either from fecal or tissue samples (Collins 1996). Problems 
with bacterial culture are for example the cost of the test and the requirement to 
decontaminate the sample to kill all the other bacteria, if fecal samples are used (Collins 
1996). Also MAP requires at least 12–16 weeks of incubation before a reliable positive 
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result can be read (Collins 1996). A cost-effective way to detect a MAP infected herd is 
to use pooled fecal samples tested by bacterial culture (Wells et al. 2003). Pooled fecal 
samples are most sensitive in herds with animals which shed moderate to high amounts 
of the bacterium (Wells et al. 2003). 
 
3.6.2 Treatment and prevention 
There is no definitive cure for infections with MAP or for JD (Fecteau & Whitlock 
2011). In the United States, there are no drugs allowed to be used for food animals in 
the treatment of JD (Fecteau & Whitlock 2011). Culling of clinical cases of JD is 
recommended (Garry 2011). Vaccination might be used to help control JD in heavily 
infected herds where other control methods have been unsuccessful (Whitlock 2010). 
Currently vaccination is not used in any country to control JD in general (de Lisle 
2010). Problems with the vaccine are the possible false-positive results in bovine 
tuberculin test (de Lisle 2010). 
 
The best treatment option for JD is to prevent the disease of spreading to the farm 
(Fecteau & Whitlock 2011). For a herd free of JD, the most important way to remain 
that status is to buy new animals from JD free herds and animals that have been tested 
for the disease (Wells et al. 2000). A primary method JD can be controlled at the farm 
level is through implementation of a JD control program utilizing assessment and herd 
management plans (USDA 2010). Also important in controlling JD at the farm level is 
to prevent exposure of susceptible animals such as calves to the bacterium and to 
identify and cull infected animals from the herd (Garry 2011). 
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4 JOHNE’S DISEASE IN FINLAND 
 
In Finland, JD is a notifiable disease and veterinarians have to report positive cases to 
the Regional State Administrative Agencies (Decree of the Ministry of Agriculture and 
Forestry 1010/2013, Section 1). When positive cases are found, no restrictions are given 
to the farms (Seuna & Seppänen 2003). Also all control measures at the farm level are 
voluntary (Seuna & Seppänen 2003).  
4.1 Testing and positive cases  
Before the 1990’s, the last reported case of JD in Finland was in 1918 (FAO 1990). In 
the early 1990’s, it was assumed that Finland was free of JD and testing of animals was 
started to attain a free country status (Seuna & Seppänen 2003) The first positive 
clinical case in over 70 years was found at the end of 1992 (Hintikka & Seuna 1998, 
Seuna & Seppänen 2003). In 1993–1994, practically all beef breeder herds in Finland 
were tested for JD by ELISA with a total of 2,893 samples (Hintikka & Seuna 1998, 
Seuna & Seppänen 2003). Of those, 35 serum samples (1%) were positive by ELISA 
but the results were not confirmed by bacterial culture (Hintikka & Seuna 1998, Seuna 
& Seppänen 2003). In 1994, 678 blood samples mostly from dairy cattle were tested 
and eight of those samples (1%) were positive by ELISA (Hintikka & Seuna 1998). 
Three of these positive samples were also positive with complement fixation method 
(Hintikka & Seuna 1998). In 1995–1996 the quantities of samples tested were low. Four 
positive samples were found in 1995 by ELISA and two in 1996 (Hintikka & Seuna 
1998). In 1992–1996, 189 samples from sheep were tested by CF method and no 
positive cases were found (Hintikka & Seuna 1998).  
 
Since October 2005, Finnish Food Safety Authority has had a project to find out the 
prevalence of clinical cases of JD in Finland. Producers and veterinarians can send 
samples of animals with clinical signs to be analyzed for JD free of charge. The samples 
can be fecal or blood samples from live cattle or organ sample from slaughterhouses or 
from necropsies. Approximately 10 samples per year have been sent thus far. No 
positive results have been found at the time of publication of this thesis. The project is 
still in progress. (Seppänen J, Finnish Food Safety Authority Evira, personal 
communication, March 2014). 
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In total, five beef herds were found positive for JD in Finland between 1992 and 2000 
(Evira 2007). Also two positive cases in farmed wild ruminants were found in 2003 and 
2007 (Evira 2007).  
 
4.2 Risk of Johne’s disease in Finland 
A risk assessment of JD in Finnish suckler herds has been made in 2004 (EELA 2004). 
The risk assessment report notes that the biggest risk of JD to spread into a herd in 
Finland is by bought animals (EELA 2004). Imported animals pose a bigger risk than 
those of domestic origin (Seuna & Seppänen 2003). The Association for Animal 
Disease Prevention Organization (ETT) provides instructions for producers importing 
cattle (ETT 2014b). The imported animals must be examined for JD by ELISA or 
bacterial culture. The tests must be completed before the cattle are imported into 
Finland (Seuna & Seppänen 2003).  
 
Control measures for JD in Finland at a national level could include establishing a 
voluntary control program, including the disease in the list of notifiable diseases, 
educating producers and veterinarians about the disease, providing more funds into 
controlling the disease (EELA 2004). The producers should also follow the import 
instructions of ETT (EELA 2004). 
 
 
5 JOHNE’S DISEASE AND CONTROL PROGRAMS IN THE UNITED STATES 
5.1 Dairy cattle 
The National Animal Health Monitoring System (NAHMS) is a program within the 
United States Department of Agriculture (USDA) that conducts nationwide studies to 
provide information about the health and management of U.S. livestock and poultry 
(USDA 2014). The Dairy 1996 study, which represented 79% of the U.S. dairy cow 
population in 20 states, found the adjusted cow-level seroprevalence of JD to be 3% 
tested with ELISA (NAHMS 1997). At the herd-level, the apparent prevalence was 22% 
(NAHMS 1997).  
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In the Dairy 2002 study, a total of 7,272 fecal samples were taken from 62 operations in 
20 states of which 9% were positive by bacterial culture (NAHMS 2002). In the study, 
15,167 milk samples were also taken in 17 states and the samples were tested by milk 
ELISA and 3% of the samples were positive (NAHMS 2002). In total, 19,378 serum 
samples from 106 operations were tested in 21 states with a commercially available 
serum ELISA and of those samples, 6% were positive or strong positive (NAHMS 
2002). These positive serum ELISA results were confirmed by milk ELISA and 46% of 
the cases were positive (NAHMS 2002). The study also included environmental 
samples from 98 farms which were taken from sites where the manure accumulates 
from a majority of adult cattle (NAHMS 2002). At least one positive sample was found 
on 70% of the study farms (NAHMS 2002). 
 
In the Dairy 2007 study, environmental samples were collected from 524 operations in 
17 states representing 80% of U.S. dairy operations and 83% of U.S. dairy cows 
(APHIS 2007). From each operation, six combined manure samples were taken. MAP 
was isolated from at least one sample on 68% of the farms (APHIS 2007). 
 
5.2 Beef cattle 
The Beef ‘97 study estimated the seroprevalence of JD in U.S. beef cattle (Dargatz et al. 
2001). In total 10,371 blood samples were taken on 380 operations in 21 states and of 
these, 40 samples (0.4%) were found positive and 30 herds (8%) had at least one 
seropositive animal tested by ELISA (Dargatz et al. 2001). 
 
In a study made in Texas in 2000–2001, samples from 4,579 beef cattle from 115 
ranches were taken (Roussel et al. 2005). The blood samples were tested by ELISA and 
137 (3%) of them were positive and 50 (44%) of the herds had at least one seropositive 
animal (Roussel et al. 2005). 
 
 
 
 12 
 
5.3 Sheep 
The Sheep 2001 study covered sheep producers from 22 states represented 42% of the 
sheep producers and 93% of ewes in the country (NAHMS 2003). Data were collected 
from 1,101 operations that had 20 or more ewes and the producers were asked which 
diseases were present (suspected or confirmed) on the farms during the previous 3 years 
(NAHMS 2003). JD was reportedly present on 2% of the farms but only 33% of these 
cases were confirmed by laboratory testing (NAHMS 2003). 
 
5.4 Minnesota 
Wells et al. (2008) gathered information from Minnesota Board of Animal Health 
(MBAH) database of herds participating in the Voluntary Bovine Minnesota Johne’s 
Disease Control Program (MNJDCP) which is a state-level JD control program. They 
found that in Minnesota in 2001 in dairy herds, the apparent cow-level seroprevalence 
of JD was 9% and in beef herds 5% (Wells et al. 2008). By 2006 the seroprevalence had 
decreased to 3% in dairy herds and 0.3% in beef herds (Wells et al. 2008). The 
participation of producers in the program increased during the study (Wells et al. 2008). 
In 2001, 146 dairy herds and 11 beef herds were included in the prevalence estimation, 
and in 2006, 380 dairy herds and 52 beef herds of herds participated in the study (Wells 
et al. 2008). 
 
In a study made in Goodhue County, Minnesota, 157 dairy herds, of which JD infection 
status was known for 125 herds, were tested for JD (Wells SJ, unpublished). Both fecal 
and blood samples were taken from the environment and from individual animals 
(Wells SJ, unpublished). Of the herds, 27 were positive by PCR and 30 herds by 
bacterial culture so the detected herd-level prevalence was thus 46% (Wells SJ, 
unpublished). 
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5.5 Johne’s disease control programs in the United States 
In the United States, all the control programs are voluntary to producer participation 
(Ferrouillet et al. 2009, USDA 2010). Each state has its own program and the programs 
have different levels of participation with different requirements (USDA 2010). The 
herds can be classified into six different levels within the program depending on their 
test results, number of positive animals and years in the program (USDA 2010). 
 
In addition to the Minnesota JD Control Program, in Minnesota there is a voluntary JD 
Demonstration Herd Project whose purpose is to demonstrate whether the use of herd 
management practices would be able to control and reduce the transmission of the 
disease (Ferrouillet et al. 2009). 
 
 
6 CROHN’S DISEASE 
 
Inflammatory bowel disease (IBD) encompasses two forms of chronic intestinal 
inflammation, ulcerative colitis (UC) and Crohn’s disease (CD) (Podolsky 1991). CD 
can occur in people at any age but typically the disease is diagnosed in teenagers and 
young adults (Hanauer et al. 2001). UC and CD share many similarities in 
epidemiology and clinical signs but they are thought as two distinct diseases (Sands & 
Siegel 2010). UC is confined to the large bowel and CD can be found in the entire GI 
tract (Sands & Siegel 2010, Osterman & Lichtenstein 2010). Also the inflammation in 
UC is diffuse and in CD it is more focal (Osterman & Lichtenstein 2010, Sands & 
Siegel 2010). Skip lesions (patchy areas of inflammation) and granulomas are also 
distinctive in CD (Sands & Siegel 2010). 
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6.1 Etiology 
The etiology of JD is not known but it is believed to be multifactorial (Sartor 2006). 
Genetic susceptibility, environmental triggers, luminal microbial antigens and adjuvants 
and immune response of the individual all have a role in the development of the disease 
(Sartor 2006). A person with a first- or a second-degree relative with inflammatory 
bowel disease has a 10–15% chance of getting the disease themselves (Stenson & 
Korzenik 2003). Studies done with monozygotic twins have found concordance rates 
for CD to be around 50% (Orholm et al. 2000, Halfvarson et al. 2003). Genes 
specifically associated with CD are for example NOD2/CARD15, ATG16L1 and IRGM 
(Russel et al. 2004, Cho 2008). Several risk factors associated with the development of 
CD have also been suggested, including smoking, infectious agents such as MAP and 
adherent-invasive Escherichia coli, socio-economic status and diet (Chiodini et al. 
1984, Somerville et al. 1984, Barnich & Darfeuille-Michaud 2007, Carbonnel et al. 
2009).  
 
Also other, unknown environmental factors may have an impact in the development of 
the disease. Clusterings of CD have been found for example in Mankato, Minnesota 
where seven out of 285 students of the Mankato High School Class of 1980 had CD 
after 19 years of graduation (Van Kruiningen & Freda 2001). None of the CD patients 
were related to each other and all of the patients had been swimming in a pond and lake 
in Mankato (Van Kruiningen & Freda 2001). Also extraordinarily high coliform counts 
were measured from Blue Earth River in Mankato (Van Kruiningen & Freda 2001). 
Blue Earth River provides 75% of the drinking water in Mankato (Van Kruiningen & 
Freda 2001). Another cluster of CD has been found in Gloucestershire, England in 1986 
(Allan et al. 1986). In a town with 1,800 people, twelve patients of CD were found and 
only two of them (a father and daughter) were related (Allan et al. 1986). Pickup et al. 
(2005) suggested an environmental exposure to MAP in South Wales, United Kingdom 
where in an area with endemic JD an increase in CD had been noticed in the population 
of 11 districts directly bordered or immediately adjacent to the river Taff. The 
catchment area of the river contains 1,013 farms with a total of 30,435 cattle. MAP 
DNA was detected by PCR in 33% (31/96) of Taff river water samples taken within one 
year (Pickup et al. 2005). The authors also propose exposure to MAP through wind and 
aerosols based on the geographical location of the districts with the increase of JD 
compared to the river Taff (Pickup et al. 2005). 
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6.2 Global prevalence and incidence 
The prevalence and incidence of CD is high in Europe and North America (Stone et al. 
2003, Loftus 2004, Bernstein et al. 2006, Manninen et al. 2010). In Stockholm County, 
Sweden the prevalence of CD was 213 per 100,000 in 2002 and the incidence was 8 per 
100,000 in 1990–2001 (Lapidus 2006). In Denmark the prevalence of CD was 151 per 
100,000 and the incidence in women 11 per 100,000 and in men 9 per 100,000 in 1998–
2002 (Jacobsen et al. 2006). In Germany, large nationwide studies have not been 
conducted but in a study in rural southern Germany the incidence of CD was 7 per 
100,000 in 2004−2006 (Ott et al. 2008). Among the highest prevalence and incidence of 
CD ever reported are the results from the Canadian province of Nova Scotia with 
prevalence of 319 per 100,000 in 1998–2000 and annual incidence of 20 per 100,000 in 
1998–2000 (Bernstein et al. 2006). In contrast, the incidence and prevalence of CD are 
lower in South America and Asia although the figures are increasing (Loftus 2004). For 
example the incidence was 0.9 per 100,000 in Korea in 2001–2005 and 0.7 in Uruguay 
in 2007– 2008 (Yang et al. 2008, Buenavida et al. 2011).  
 
6.3 Clinical signs 
CD is characterized by acute and chronic inflammation of the small and large intestine 
and other parts of the gastrointestinal tract (Lashner 2000). CD can be found in the 
entire gastrointestinal tract (Stenson & Korzenik 2003). Depending on the site of the 
disease the symptoms include abdominal pain, weight loss, steatorrhea, diarrhea, 
hematochezia and fever (Lashner 2000).  
 
6.4 Pathogenesis and pathologic findings 
The most widely agreed theory of the pathogenesis of inflammatory bowel disease is 
that commensal enteric bacteria excessively activate T cells to develop aggressive 
immune responses which will ultimately lead to chronic intestinal inflammation in 
genetically susceptible humans (Sartor 2006). Environmental factors are required in and 
enhance this activation (Sartor 2006). Also commensal bacteria of the gut are believed 
to play a role in the pathogenesis of IBD since it has been noted that in transgenic mice, 
resident enteric bacteria are required for development of spontaneous colitis and that the 
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diversity of enteric microbiota is reduced by 50% in CD (Sellon et al. 1998, Ott et 
al.2004, Sartor 2006). 
 
The most distinctive pathologic finding in CD is focal intestinal inflammation (Sands & 
Siegel 2010). The inflammation in the intestine is often transmural and the disease can 
be associated with intestinal granulomas, strictures and fistulas (Abraham & Cho 2009). 
The iliocecal region of the bowel is affected as an initial site in about 40% of the 
patients, small intestine in 30% and colon in 25% of patients (Lashner 2000). In one 
third to one half of all patients the disease affects both ileum and colon (Sands & Siegel 
2010). 
 
6.5 Diagnosis and treatment 
The diagnosis of CD is based on clinical signs, medical history and on the results of 
laboratory tests, endoscopy, imaging studies such as CT and MRI and on pathologic 
findings (Baumgart & Sandborn 2012). With endoscopic studies the visualization of the 
mucosa of the intestine is possible thus enabling to assess the extent of inflammation in 
the gut (Sands & Siegel 2010). Ileocolonoscopy with biopsies is used as a golden 
standard to diagnose CD (Baumgart & Sandborn 2012).  
 
Since CD is a non-curable disease, the aim is to induce and maintain remission and to 
improve the quality of life of the patient (Sands & Siegel 2010). The treatment is based 
on medical, nutritional and surgical therapy (Baumgart & Sandborn 2012). Medication 
used for CD patients varies quite a lot based on the site and activity of the disease 
(Dignass et al. 2010). Common drugs are aminosalicylates such as sulfasalazine; 
corticosteroids, antibiotics such as metronidazole and immunosuppressive drugs such as 
azathioprine and mercaptopurine (Sands & Siegel 2010). No specific diet can be 
recommended for CD patients but since common symptoms of the disease are weight 
loss and malnutrition, sufficient supplementation of nutrients and calories in the diet is 
necessary (Sands & Siegel 2010). Smoking promotes fistulising and it might worsen the 
effect of medical therapy (Baumgart & Sandborn 2012). Surgical therapies include 
resections, bypass surgery and repair or resection of fistulas but surgery should not be 
regarded as a primary therapy (Sands & Siegel 2010, Baumgart & Sandborn 2012).  
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7 CROHN’S DISEASE IN FINLAND 
 
 In Finland, all permanent residents are covered by the National Health Insurance 
scheme which reimburses a share of medical costs and cost of drugs prescribed by a 
physician (Kela 2014b). Therefore nationwide prevalence and incidence studies are easy 
to conduct as statistics on the prescription of drugs specific to a certain disease is 
available (Kela 2014a). 
 
The incidence and prevalence of CD in adults in Finland are represented in Table 1. The 
incidence of CD in children in Finland is represented in Table 2. Both the incidence and 
prevalence of CD are increasing in adults and the incidence of pediatric CD is 
increasing in Finland (Tables 1 and 2). 
 
 a
NR Not reported 
  
Table 1 Incidence and prevalence of Crohn’s disease in adults in Finland 
Study 
period 
Area 
Incidence/ 
100,000 
Prevalence/
100,000 
Reference 
1975 Helsinki 1.0 NR
a
 Halme et al. 1989 
1985 Helsinki 3.0 NR Halme et al. 1989 
1986 Tampere 5.0 40.0 Manninen et al. 2010 
1993 nationwide NR 38.0 Jussila et al. 2013 
1999 Tampere 9.4 124.0 Manninen et al. 2010 
2000–
2007 
nationwide 9.2 NR
 
Jussila et al. 2012 
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8 CROHN’S DISEASE IN THE UNITED STATES 
8.1 Adults 
Inflammatory bowel disease is not a reportable condition in the United States and there 
are no national registries for the disease in the country (Kappelman et al. 2007). 
Therefore large population based studies are difficult to execute (Kappelman et al. 
2007). The Mayo Clinic, established in Rochester, Minnesota is a highly distinguished 
referral hospital which is ranked highest in gastroenterology in the United States in 
2013−2014 (U.S. News & World Report 2014). They have conducted studies on CD 
since 1940’s in Olmsted County, Minnesota (Loftus et al. 2007). The incidence and 
prevalence of CD in adults the United States including Minnesota are represented in 
Table 3. The incidence of CD in Minnesota has risen dramatically from the 1940’s 
(Table 3). The prevalence of CD in Minnesota has risen from 91/100,000 to 
222/100,000 in 25 years (Table 3). Minnesota used to have the highest prevalence 
numbers of CD in the United States but new research findings show that the incidence 
and prevalence of CD are increasing in the whole country (Table 3). 
 
 
Table 2 Incidence of Crohn’s disease in children in Finland 
Study 
period 
Age range, 
years 
Area 
Incidence/ 
100,000 
Reference 
1987 0–17 
Helsinki 
and 
Tampere 
1.7 Turunen et al. 2006 
1992 0–17 nationwide 2.2 
Lehtinen P, personal 
communication February 2012 
1992–2003 0–17 nationwide 3.7 Lehtinen  et al. 2011 
2003 0–17 
Helsinki 
and 
Tampere 
2.6 Turunen et al. 2006 
2003 0–17 nationwide 5.3 
Lehtinen P, personal 
communication Febryary 2012 
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Table 3 Incidence and prevalence of Crohn’s disease in adults in the United States and 
Minnesota 
Study 
period 
Area 
Incidence/
100,000 
Prevalence/
100,000 
Reference 
1996–2002 Northern California 6.3 NRa Herrinton et al. 2008 
1999–2001 nationwide NR 129.0 Herrinton et al. 2007 
2002 Northern California NR 96.0 Herrinton et al. 2008 
2004 
33 states in the 
U.S. 
NR 201.0 Kappelman et al. 2007 
2009 nationwide 20.0 241.0 Kappelman et al. 2011 
2009 
nationwide, 
military health care 
system 
NR 180.0 Betterridge et al. 2013 
1940–1949 
Olmsted County, 
MN 
2.3 NR Loftus et al. 2007 
1980–1989 
Olmsted County, 
MN 
6.8 NR Loftus et al. 2007 
2001–2004 
Olmsted County, 
MN 
12.9 NR Ingle et al. 2007 
1980 
Olmsted County, 
MN 
NR 91.0 Gollop et al. 1988 
2001 
Olmsted County, 
MN 
NR 174.0 Loftus et al. 2007 
2005 
Olmsted County, 
MN 
NR 222.0 Ingle et al. 2007 
a
NR Not reported 
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8.2 Children 
The incidence and prevalence of CD in children in the United States and Minnesota are 
represented in Table 4. The prevalence of CD in children is significantly higher in 
Minnesota than in the rest of the country (Table 4). The incidence in children between 
Minnesota and the rest of the country is difficult to compare due to the lack of incidence 
studies in Minnesota (Table 4). 
 
Table 4 Incidence and prevalence of Crohn’s disease in children in the United States 
and Minnesota 
Study 
period 
Age 
range, 
years 
Area 
Incidence/ 
100,000 
Prevalence/
100,000 
Reference 
1996–
2006 
0–17 
Northern 
California 
2.7 NR
a 
Abramson et al. 2010 
2000–
2001 
0–17 Wisconsin 4.6 NR 
Kugathasan et al. 
2003 
2004 2–19 33 states NR 43.0 
Kappelman et al. 
2007 
2006 0–17 
Northern 
California 
NR 12.0 
Abramson et al.  
2010 
1940–
2000 
0–19 
Olmsted 
County, 
MN 
2.4 NR Loftus et al. 2007 
2001 0–19 
Olmsted 
County, 
MN 
NR 115.0 Loftus et al. 2007 
2009 0–19 nationwide 12.0 58.0 
Kappelman et al. 
2011 
2009 0–19 nationwide NR 40.0 
Betterridge et al. 
2013 
a
NR
 
Not reported 
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9 MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS AND CROHN’S 
DISEASE 
 
The idea of the possible link between MAP and CD was first introduced in 1913, when 
similar pathological findings in patients of CD and in cattle with JD were discovered 
(Dalziel 1913). The connection was first experimentally associated in 1984 after the 
culture of MAP from intestinal tissues of 3 out of 11 CD patients (Chiodini 1984). Since 
then a lot of speculation has surrounded the question but no definite proof of the 
causative link has been found (Shanahan & O’Mahony 2005).  
 
9.1 Mycobacterium avium subsp. paratuberculosis in Crohn’s disease patients’ tissues 
MAP has been found in CD patients’ tissue samples in several studies. A systemic 
review and meta-analysis made by Feller et al. (2007) concluded that MAP DNA was 
found by PCR in CD patients’ tissues or blood more often than in controls in 16 of 18 
studies. The odds ratio (OR) ranged from 2 to 32 and the pooled OR was 7 in those 16 
studies (Feller et al. 2007). By ELISA, in 10 of 13 studies, MAP antibodies were more 
likely to be detected in CD patients than in controls. In these studies, the OR ranged 
from 1 to 12 with a pooled OR of 2 (Feller et al. 2007). In addition to the occurrence of 
MAP DNA in CD patients’ tissues, MAP has also been cultured from blood and breast 
milk of humans (Naser et al. 2000, Naser et al. 2004, Mendoza et al. 2010).  
 
9.2 Occupational exposure to Mycobacterium avium subsp. paratuberculosis 
Since MAP is shed in the feces of infected animals it is logic to consider the possible 
exposure to be bigger among people who work with animals, e.g. farm workers and 
veterinarians than among those with no or limited animal contact. Also the consumption 
of raw milk among dairy farmers could be presumed to be higher than among normal 
consumers. Therefore the prevalence of JD and the occurrence of MAP in tissues would 
be higher among these occupational groups. But this has been proven wrong at least in 
one study by Qual et al. (2010). They studied the occurrence of MAP in tissues of 
almost 1,500 dairy and beef cattle producers and veterinarians in the United States 
(Qual et al. 2010). Of the farmers, 66% were in contact with cattle infected with MAP 
and of the veterinarians the figure was 56% (Qual et al. 2010). Even though the 
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prevalence of CD was high among the study group (474/100,000), they didn’t find a 
statistically significant association between the exposure to MAP and CD (Qual et al. 
2010). A questionnaire study in England didn’t find an association between the 
exposure to JD positive cattle and CD (Jones et al. 2006).  In India on the other hand, 
the occurrence of viable MAP in stool samples of animal attendants working with goats 
suffering from gastrointestinal symptoms was found to be 50% (Singh et al. 2011). 
 
9.3 Controversy  
The proposed association between MAP and CD has proven to be quite complex and 
controversial (Sartor 2005). Sartor (2006) suggests that in certain genetically susceptible 
individuals a persistent pathogen such as MAP could cause CD. There is controversy on 
whether MAP is only a commensal bacterium accidentally found in human gut tissue or 
if it is truly a pathogen causing disease (Sartor 2005). Even though MAP has been 
found in CD patients’ tissues in several studies, it is not the case every time. For 
example Parrish et al. (2009) were not able to culture MAP from CD patients’ or 
healthy controls’ blood. In a large number of studies, MAP is also found in healthy 
controls’ tissues, but the selection of the control group has not always been optimal 
(Feller et al. 2007). A two-year combination antibiotic therapy study with 
clarithromycin, rifabutin and clofazimine, antibiotics able to kill mycobacteria, did not 
find evidence of benefit in the treatment of active JD (Selby et al. 2007). The study 
didn’t examine the occurrence of MAP in the study population’s tissues. Therefore the 
efficacy of the treatment is impossible to evaluate correctly because it could be that only 
a small portion or none at all of the study population were infected by MAP. 
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10 HUMAN EXPOSURE TO MYCOBACTERIUM AVIUM SUBSP. 
PARATUBERCULOSIS 
10.1 Food 
National Advisory Committee on Microbiological Criteria for Foods (NACMCF) has 
assessed the importance of food as a source of exposure to MAP (NACMCF 2010). 
NACMCF provides scientific advice to U.S. federal food safety agencies (FSIS 2014). 
MAP is shed in feces and milk of infected animals (Sweeney 1996). Therefore dairy 
products and meat products originating from infected animals including dairy and beef 
cattle, sheep and goats may serve as a potential source of exposure to MAP (NACMCF 
2010). In their report, NACMCF concluded that milk, especially unpasteurized raw 
milk, may be a significant source of human exposure to MAP (NACMCF 2010). They 
also suggest that ground beef may a potential source of MAP (NACMCF 2010). One 
possible way food may become contaminated with MAP is during processing such as 
contamination of carcasses in slaughter plants and meat processing plants (Eltholth et 
al. 2009). In addition to meat, also dairy products can become contaminated with MAP 
during processing e.g. by fecal contamination or by mixing of pasteurized and raw milk 
(Eltholth et al. 2009). Since MAP is shed to feces and is so persistent in the 
environment, it is possible that runoffs from farms will lead to contamination of 
irrigation water. This again can lead to contamination of vegetables and fruits 
(NACMCF 2010).  
 
10.2 Drinking water 
Drinking water can become contaminated with pathogenic bacteria if cattle manure is 
applied to fields as fertilizer (Thurston-Enriquez et al. 2005). The bacteria in the manure 
can enter water resources such as ground, irrigation, surface and recreational waters by 
rainfall runoffs (Thurston-Enriquez et al. 2005).  
 
Ground water accumulates underground in aquifers and it is contained beneath the 
surface in rocks and soil (Schmoll et al. 2006). Aquifers are layers of rock or sediments 
which are permeable and porous enough to filtrate and store water underground 
(Schmoll et al. 2006). Ground water rarely requires extreme water treatments to be 
suitable for drinking and sometimes it does not need any treatment at all (Schmoll et al. 
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2006). Ground water is regarded as a relatively microbially safe source of drinking 
water (Schmoll et al. 2006). Surface waters are susceptible to direct contamination but 
ground water is sheltered by the overlying soil (Schmoll et al. 2006). Despite this, fecal 
contamination of ground water is possible especially if inadequate protection of ground 
water is not performed (Schmoll et al. 2006). Also the size of the pathogen and the fines 
of the soil influence how well the pathogen can filter into ground water (Schmoll et al. 
2006).   
 
In the United States in organic production, uncomposted animal manures can be applied 
to fields 120 days before harvest for crops whose edible parts are in contact with the soil 
(Code of Federal Regulations, Title 7 Part 205). If the edible parts are not in contact 
with the soil, manure can be applied on fields 90 days before harvest. Otherwise the 
manure must be composted (Code of Federal Regulations, Title 7 Part 205). There are 
no federal or state rules on application of manure in non-organic production (FDA 
2014). In the European Union, the Council Regulation on organic production and 
labelling of organic products (No 834/2007), states that livestock manure should be 
preferably composted before applying to the field in organic production (Council 
Regulation No 834/2007, article 12). Such statements are not available for non-organic 
production. MAP DNA has been found in composting material (cattle manure, 
sawdust/straw) (Grewal et al. 2006). Grewal et al. (2006) studied the persistence of 
MAP during composting at 55°C. They were not able to culture MAP after 3 days of 
composting but the insertion element IS900 was found by PCR through day 56 from the 
composting material (Grewal et al. 2006).  
 
10.3 Other ways of exposure 
In addition to food and drinking water, other possible routes of human exposure to MAP 
are, for example, direct contact with the infected animals, exposure to contaminated 
environment through soil or water, person-to-person horizontal transmission and 
occupational exposure by farmers and veterinarians (Beumer et al. 2010, NACMCF 
2010). 
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10.4 Methods to reduce the human exposure to Mycobacterium avium subsp. 
paratuberculosis 
It is challenging to prevent the exposure of humans to MAP since the bacterium is shed 
to milk and feces of infected animals and subclinical infections are common (Whitlock 
& Buergelt 1996). The farm is therefore in critical role in reducing the human exposure 
to the bacterium by controlling the shedding of the bacterium (Eltholth et al. 2009). 
 
Other ways to reduce the human exposure to MAP is by reducing the number of the 
bacteria in foods. The ways include for example pasteurization of milk, cooking of meat 
and water treatment techniques such as chlorination and ultraviolet irradiation 
(NACMCF 2010).  
 
Whittington et al. (2010) noticed that temperatures used in cooking red meat are able to 
reduce the number of MAP in lamb significantly. Saucier & Plamondon (2011) boiled 
ground beef patties inoculated with MAP strains and came to a conclusion that normal 
cooking temperatures (70°C) are enough to control low concentrations of MAP in 
ground beef. 
 
Chlorine is widely used in water treatment plants to produce safe drinking water since it 
kills most of the pathogenic bacteria (WHO 2011). The World Health Organization 
(WHO) recommends a guideline value for chlorine in water treatment to be 5.0 mg/l 
(5000 µg/ml) and the concentration of chlorine at the point of delivery to the customer 
should be at least 0.2 mg/l (200 µg/l) (WHO 2011). Throughout the world chlorine is 
present in most disinfected drinking water at concentrations of 0.2–1.0 mg/l (WHO 
2011). In Helsinki region in Finland, the concentration of chlorine varies between 0.4–
0.5 mg/l (HSY 2014a). In Minneapolis the concentration of chlorine in drinking water is 
about 3.0 mg/l (City of Minneapolis 2014b). Whan et al. (2001) found that chlorine 
used with levels of 0.5, 1.0 and 2.0 µg/ml (0.5, 1.0, 2.0 mg/l) did not kill all human and 
bovine strains of MAP when the cell concentration of MAP was 10
6
 colony forming 
units (cfu)/ml. When they added bovine serum albumin to mimic organic matter often 
present in drinking water the effect of chlorine was reduced but the effectiveness was 
not significant (Whan et al. 2001). 
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Altic et al. (2007) studied the effect of UV radiation on the survival of MAP in 
semiskim and whole milk and noticed 0.5–1.0 log10 reductions in the number of MAP at 
1000 mJ/ml. Donaghy et al. (2009) noticed 0.1–0.6 log10 reductions in the number of 
MAP in whole milk at 1000 mJ/ml.  
 
The papers studying the heat resistance of MAP give widely differing results and since 
the studies have used very different conditions, the results are difficult to compare 
(Lund et al. 2002). Five of the nine studies reviewed by Lund et al. (2002) reported 
more than a 4 decimal reduction of MAP when the sample was heated at 72°C for 15 s 
(high temperature short time (HTST) pasteurization method). MAP has been found to 
be very persistent in the environment. MAP remained culturable in lake water 
microcosm for 632 days and the bacterium persisted detectable by real time PCR in the 
microcosm for 841 days (Pickup et al. 2005). Jørgensen (1977) found that MAP can 
survive viable in cattle and swine slurry in 5°C for 252 days and in cattle slurry for 98 
days in 15°C. Whittington et al. (2004) cultured MAP from soil contaminated with 
sheep feces containing MAP after 55 weeks. 
 
 
11 THE OCCURRENCE OF MYCOBACTERIUM AVIUM SUBSP. 
PARATUBERCULOSIS IN FOOD AND WATER 
 
The occurrence of MAP in food and water has been studied quite a lot. A compilation of 
the studies is represented in tables 5−9. 
 
In asymptomatic animals, the infection status of the animals was not always known, as 
shown in Table 5. Therefore the results may be a bit difficult to compare and interpret. 
However, it can be noted that there are more positive results by PCR than by culture. 
That can be due to that PCR is a more sensitive detection method than culture and that 
culture of MAP requires decontamination of the samples. This might also reduce the 
number of MAP in the sample. Also PCR detects both dead and viable cells so it is 
natural that the percentage of MAP is higher by PCR than culture.  
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There are more positive results in the individual animals’ results than in bulk tank milk 
results but that is logic since the bulk tank samples are taken from large tanks where the 
milk of several cows is mixed. Therefore the number of MAP might be too low for 
detection by the methods used. Raw bulk tank milk and retail pasteurized milk results 
can be assumed to be comparable with one another since the samples are both taken 
from large quantities of milk. The results vary a lot between studies. Some were not 
able to culture MAP at all or the percentages are small and others such as Javarao et al. 
(2004) were able to culture MAP in almost 1/3 of the samples from raw bulk tank milk. 
None of the papers used Finnish milk as a sample but MAP was found in several studies 
in the U.S. In general the occurrence of MAP in retail pasteurized milk is fairly low but 
still MAP has been able to culture in pasteurized milk in several studies. 
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Table 5 The occurrence of MAP in milk 
 
 
    Positive 
samples 
  
Species Country Disease status Sample type Detection method 
No (%) 
 
Detection 
limit 
Reference 
cow UK asymptomatic 
raw bulk tank 
milk 
IMS-PCRa (IS900) 19/244 (8) 1 cfu/50 ml Grant et al. 2002 
cow UK asymptomatic 
raw bulk tank 
milk 
culture (BACTECb, 
HEYMc) 
4/244 (2) 10 cfu/50 ml Grant et al. 2002 
cow Ireland asymptomatic 
raw bulk tank 
milk 
culture (BACTEC & 
HEYM) 
0/310 (0) 100 cfu/50 ml O’Doherty et al. 2002 
cow Spain asymptomatic 
raw bulk tank 
milk 
PCR (IS900) 23/270 (9) NDd Sevilla et al. 2002 
cow Switzerland asymptomatic 
raw bulk tank 
milk 
PCR (IS900) 112/501 (22) ND Stephan et al. 2002 
cow USA asymptomatic 
raw bulk tank 
milk 
culture (HEYM) 6/29 (21) ND Jayarao et al. 2004 
cow USA asymptomatic 
raw bulk tank 
milk 
PCR (IS900) 8/29 (28) ND Jayarao et al. 2004 
cow USA asymptomatic  raw milk culture (HEYM) 43/1493 (3) ND Jayarao et al. 2004 
cow USA asymptomatic raw milk PCR (IS900) 201/1493 (13) ND Jayarao et al. 2004 
cow 
the Czech 
Republic 
asymptomatic raw milk culture (HEYM) 15/483 (3) ND Ayele et al. 2005 
cow 
the Czech 
Republic 
fecal culture 
negative 
raw milk culture (HEYM) 1/268 (0.4) ND Ayele et al. 2005 
cow Switzerland asymptomatic 
raw bulk tank 
milk 
PCR (f57) 3/100 (3) 100 cfu/ml Bosshard et al. 2006 
cow Iran asymptomatic 
raw bulk tank 
milk 
nPCRe (IS900) 12/110 (11) ND Haghkhah et al. 2008 
cow Cyprus asymptomatic 
raw bulk tank 
milkf 
 
culture (HEYM) 
 
0/22 (0) 
 
ND 
 
Slana et al. 2009 
cow Cyprus asymptomatic 
raw bulk tank 
milkf 
qPCRg (IS900) 49/220 (22) 5−6 cfu/ml Slana et al. 2009 
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Table 5 Continued 
 
 
    Positive 
samples 
  
Species Country Disease status Sample type Detection method 
No (%) 
 
Detection 
limit 
Reference 
cow Cyprus asymptomatic 
raw bulk tank 
milkf 
qPCR (f57) 14/220 (6) 83 cfu/ml Slana et al. 2009 
cow India NKh raw retail milk culture (HEYM) 7/16 (44) ND Shankar et al. 2010 
cow India NKh raw retail milk PCR (IS900) 1/16 (6) ND Shankar et al. 2010 
cow USA 
fecal culture 
positive 
raw milk culture (HEYM) 9/77 (12) ND Sweeney et al. 1992 
cow Denmark clinically infected raw milk culture (LJMi) 5/11 (45) 100 cfu/ml Giese & Ahrens 2000 
cow Denmark clinically infected raw milk PCR (IS900) 2/11 (18) 1000 cfu/ml Giese & Ahrens 2000 
cow USA 
fecal culture 
positive 
raw milk PCR (IS900) 69/211 (33) 
10−100 
cfu/ml 
Pillai & Jayarao 2002 
cow USA 
fecal culture 
positive 
raw milk culture (HEYM) 9/211 (4) 
10−100 
cfu/ml 
Pillai & Jayarao 2002 
cow USA seropositive herd 
raw bulk tank 
milkj 
culture (HEYM) 0/52 (0) < 10 cfu/ml Stabel et al. 2002 
cow USA seropositive herd 
raw bulk tank 
milkj 
PCR (IS900) 35/52 (67) ND Stabel et al. 2002 
cow USA infected herd 
raw bulk tank 
milk 
 
PCR (IS900) 
 
11/21 (52) 
 
ND 
 
Stabel et al. 2002 
cow USA 
fecal culture 
positive 
raw bulk tank 
milk 
PCR (IS900) 10/20 (50) 
10−100 
cfu/ml 
Pillai & Jayarao 2002 
cow USA 
fecal culture 
positive 
raw bulk tank 
milk 
culture (HEYM) 1/20 (5) 
10−100 
cfu/ml 
Pillai & Jayarao 2002 
cow USA, 10 states infected herd 
raw bulk tank 
milk 
PCR (IS900) 24/31 (77)  ND Stabel et al. 2002 
cow 
the Czech 
Republic 
fecal culture 
positive 
raw milk culture (HEYM) 14/76 (18) ND Ayele et al. 2005 
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Table 5 Continued 
 
 
    Positive 
samples 
  
Species Country Disease status Sample type Detection method 
No (%) 
 
Detection 
limit 
Reference 
cow Denmark 
fecal culture 
positives & 
negatives 
raw bulk tank 
milk 
RT-PCR (IS900) 19/143 (13) 1−10 cfu/ml Herthnek et al. 2008 
cow Mexico seropositive 
raw bulk tank 
milk 
PCR (IS900) 14/14 (100) ND Favila-Humara et al. 2010 
cow Mexico seropositive 
raw bulk tank 
milk 
culture (HEYM) 10/14 (71) ND Favila-Humara et al. 2010 
cow Mexico seropositive raw milk PCR (IS900) 10/10 (100) ND Favila-Humara et al. 2010 
 
cow England & 
Wales 
NK 
retail 
pasteurized milk 
culture (Dubos broth) 15/54 (28) ND Millar et al. 1996 
cow England & 
Wales 
NK 
retail 
pasteurized milk 
PCR (IS900) 22/312 (7) 
200−300 
cfu/ml 
Millar et al. 1996 
cow Canada NK 
retail 
pasteurized milk 
culture (BACTEC) 0/244 (0) ND Gao et al. 2002 
cow Canada NK 
retail 
pasteurized milk 
PCR (IS900) 110/710 (16) 100 cfu/ml Gao et al. 2002 
cow UK NK 
commercially 
pasteurized milk 
IMS-PCR (IS900) 67/567 (12) 1 cfu/50 ml Grant et al. 2002 
cow UK NK 
commercially 
pasteurized milk 
culture (HEYM, 
BACTEC) 
10/567 (2) 10 cfu/50 ml Grant et al. 2002 
cow Ireland NK 
retail 
pasteurized milk 
culture (BACTEC  & 
HEYM) 
0/77 (0) 100 cfu/50 ml O’Doherty et al. 2002 
cow 
the Czech 
Republic 
NK 
commercially 
pasteurized milk 
 
culture (HEYM) 
 
4/244 (2) 
 
ND 
 
Ayele et al. 2005 
cow 
the Czech 
Republic 
NK 
locally 
pasteurized milk 
 
culture (HEYM) 
 
2/200 (1) 
 
ND 
Ayele et al. 2005 
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Table 5 Continued 
 
 
    Positive 
samples 
  
Species Country Disease status Sample type Detection method 
No (%) 
 
Detection 
limit 
Reference 
 
cow 
 
USA (CA, MN, 
WIk) 
 
NK 
 
retail 
pasteurized milk 
culture (HEYA, ESPl) 
& confirmatory PCR 
(IS900 and hspX) 
 
20/702 (3) 
 
ND 
 
Ellingson et al. 2005 
cow 
USA, 
Minnesota 
NK 
retail 
pasteurized milk 
culture (HEYA, ESP) & 
confirmatory PCR 
(IS900 and hspX) 
9/234 (4) ND Ellingson et al. 2005 
cow 
USA (CA, MN, 
WI) 
NK 
retail 
pasteurized milk 
PCR (IS900 and hspX) 452/702 (64) 
1 cfu/reaction 
(IS900), 20 
cfu/reaction   
(hspX) 
Ellingson et al. 2005 
cow India NK 
retail 
pasteurized milk 
PCR (IS900) 7/18 (39) ND Shankar et al. 2010 
cow India NK 
retail 
pasteurized milk 
culture (HEYM) 13/18 (72) ND Shankar et al. 2010 
goat Ireland NK 
retail 
pasteurized milk 
culture (BACTEC & 
HEYM) 
0/9 (0) 100 cfu/50 ml O’Doherty et al. 2002 
goat Norway 
vaccinated 
animals, JD 
reported 
raw milk 
IMS-PCR (dot blot 
technique) 
4/120 (3) 0.1 cfu/ml Djønne et al. 2003m 
goat Norway 
vaccinated 
animals, JD never 
reported 
raw milk 
 
IMS-PCR (dot blot 
technique) 
11/100 (11) 0.1 cfu/ml Djønne et al. 2003m 
goat Norway 
not vaccinated 
animals, JD never 
reported 
raw milk 
IMS-PCR (dot blot 
technique) 
9/120 (8) 0.1 cfu/ml Djønne et al. 2003m 
goat Norway 
not vaccinated 
animals, JD never 
reported 
raw milk culture 0/340 (0) 10 cfu/ml Djønne et al. 2003m 
goat Switzerland NRn 
raw bulk tank 
milk 
PCR (IS900) 79/344 (23) ND Muehlherr et al. 2003 
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Table 5 Continued 
 
 
    Positive 
samples 
  
Species Country Disease status Sample type Detection method 
No (%) 
 
Detection 
limit 
Reference 
goat India clinically infected raw milk culture (HEYM) 1/10 (10) ND 
Singh & Vihan 2004 
 
goat Italy seropositive herd raw milk nPCR (IS900) 6/9 (67) ND Nebbia et al. 2006 
goat Greece NR 
raw bulk tank 
milk 
qPCR (IS900) 0/13 (0) <10 cfu/ml Botsaris et al. 2010 
goat Greece NR 
raw bulk tank 
milk 
culture (HEYM) 0/13 (0) ND Botsaris et al. 2010 
goat Mexico seropositive 
raw bulk tank 
milk  
PCR (IS900) 3/3 (100)  Favila-Humara et al. 2010 
goat Mexico seropositive 
raw bulk tank 
milk 
culture 3/3 (100) ND Favila-Humara et al. 2010 
goat Mexico seropositive raw milk PCR (IS900) 8/8 (100) ND Favila-Humara et al. 2010 
sheep Switzerland NR 
raw bulk tank 
milk 
PCR (IS900) 15/63 (24) ND Muehlherr et al. 2003 
sheep Australia clinically infected raw milk culture (BACTEC) 2/76 (3) ND Lambeth et al. 2004 
sheep Italy seropositive herd raw milk  nPCR (IS900) 7/20 (35) ND Nebbia et al. 2006 
sheep Greece NR 
raw bulk tank 
milk 
qPCR (IS900) 1/5 (20) <10 cfu/ml Botsaris et al. 2010 
sheep 
 
Greece 
NR 
raw bulk tank 
milk 
culture (HEYM) 0/5 (0) ND Botsaris et al. 2010 
sheep & 
goat 
Greece NR 
raw bulk tank 
milk 
qPCR (IS900) 1/19 (5) <10 cfu/ml Botsaris et al. 2010 
 
sheep & 
goat 
 
Greece 
 
NR 
 
raw bulk tank 
milk 
 
culture(HEYM 
 
0/19 (0) 
 
ND 
 
Botsaris et al. 2010 
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a
IMS Immunomagnetic separation combined with PCR 
b
BACTEC Radiometric culture 
c
HEYM Herrold Egg Yolk Medium 
d
ND No detection limit was identified 
e
nPCR Nested PCR 
f
All the dairy herds within the country 
g
qPCR Quantitative PCR 
h
NK Not known 
i
LJM Löwenstein-Jensen medium 
j
Either fecal culture positives or negatives 
k
California, Wisconsin & Minnesota 
l
ESP culture method 
m
No decontamination methods used 
n
NR Not reported
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In cheese the culture of MAP has not been really successful, as can be seen in Table 6. 
Either the amount of samples has been small or MAP has been able to culture only on 
one or two samples per one study. The reasons for this might be due to the long ripening 
process of cheese. It could be possible that MAP is destroyed during the ripening and 
thus only MAP DNA is found. An interesting fact is that MAP has been found in infant 
milk powder. If MAP is found to be an etiological agent of CD, special attention should 
be addressed on infant and children’s food because it might be that small children are 
more susceptible to mycobacterial infections than adults. 
 
In addition to milk and cheese, MAP has been cultured from other dairy products as 
well. Shankar et al. (2010) cultured MAP from pasteurized ice cream and liquid dairy 
products from 5/9 (56%) of the samples and found IS900 sequence specific to MAP in 
2/9 (22%) of the samples. One possible route of exposure to MAP could be by infant 
milk powder since milk is used in a variety of infant foods. Hruska et al. (2005) tested 
51 different dried milk infant products from ten producers. The producers came from 
seven European Union countries (Hruska et al. 2005). IS900 sequence was found in 25 
samples (49%) and fragment f57 was found in 18 samples (35%) (Hruska et al. 2005). 
Botsaris et al. (2012) were able to culture MAP from 9% of infant formula samples 
bought from Cyprus and they found IS900 sequence in 22% of the samples. Rowe et al. 
(2007) on the other hand were not able to culture MAP from milk powder but they 
found IS900 sequence in 18/190 (9%) of the samples. 
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a
NR Not reported 
b
ND
 
Not determined 
c
HEYM Herrold Egg Yolk Medium 
d
BACTEC Radiometric culture 
e
RT-PRC Real-Time PCR 
f
Middlebrook 7H10 agar with antibiotic supplement 
g
qPCR Quantitative PCR 
 
 
Table 6 The occurrence of MAP in cheese 
 
 
   
Positive 
samples 
  
Type of 
cheese 
Species Country 
Pasteur-
ized 
Detection 
method 
No (%) 
Detection 
limit 
cfu/ml 
Reference 
feta NRa Greece yes PCR (IS900) 
21/42 
(50) 
NDb Gazouli et al. 2003 
feta NR Greece yes 
culture 
(HEYMc, 
BACTECd) 
1/42 (2) ND Gazouli et al. 2003 
ND NR 
the Czech 
Republic 
yes PCR (IS900) 
5/42 
(12) 
ND 
Ikonomopoulos et 
al. 2005 
ND NR 
the Czech 
Republic 
yes 
culture 
(HEYM) 
1/43 (2) ND 
Ikonomopoulos et 
al. 2005 
feta 
sheep & 
goat 
Greece yes PCR (IS900) 
21/42 
(50) 
ND 
Ikonomopoulos et 
al. 2005 
feta 
sheep & 
goat 
Greece yes 
culture 
(HEYM) 
2/42 (5) ND 
Ikonomopoulos et 
al. 2005 
cheese 
curds 
cow USA (MI, WI) yes PCR (IS900) 
23/98 
(23) 
ND 
Clark et al. 2006 
 
cheese 
curds 
cow USA (MI, WI) yes PCR (hspX) 9/98 (9) ND 
Clark et al. 2006 
 
cheese 
curds 
cow USA (MI, WI) yes 
culture 
(HEYA) 
0/98 (0) ND 
Clark et al. 2006 
 
soft, 
semihard, 
hard 
cow Switzerland no 
RT-PCRe 
(f57) 
6/143 
(4) 
ND Stephan et al. 2007 
soft, 
semihard, 
hard 
cow Switzerland no 
culture 
(7H10-
PANTAf, 
BACTEC) 
0/143 
(0) 
50 Stephan et al. 2007 
retail 
traditional 
cheese 
cow, 
sheep & 
goat 
Greece yes 
qPCRg 
(IS900) 
7/28 
(25) 
ND Botsaris et al. 2010 
retail  
traditional 
cheese 
cow, 
sheep & 
goat 
Greece yes 
culture 
(HEYM) 
0/28 (0) ND Botsaris et al. 2010 
semihard, 
hard 
cow Scotland no 
culture 
(HEYM, 
Middlebrook) 
2/20 
(10) 
ND 
Williams & Withers 
2010 
semihard, 
hard 
sheep Scotland no 
culture 
(HEYM, 
Middlebrook) 
3/4 (75) ND 
Williams & Withers 
2010 
semihard, 
hard 
goat Scotland no 
culture 
(HEYM, 
Middlebrook) 
0/1 (0) ND 
Williams & Withers 
2010 
semihard, 
hard 
cow Scotland yes 
culture 
(HEYM, 
Middlebrook) 
2/3 (67) ND 
Williams & Withers 
2010 
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Studies conducted on the occurrence of MAP in meat have mostly concentrated on beef 
but also some studies on mutton have been done, shown in Table 7. A lot of the studies 
have been conducted on infected animals. The prevalence of JD is high in the countries 
where the studies have been made; therefore it is logic that also the animals used in the 
studies have an infection. Thus it is more relevant to estimate the exposure of humans to 
MAP through meat based on these studies.  Wells et al. (2009) were able to culture 
MAP from 172/338 (51%) of carcass swab samples after the removal of the hide but 
before any interventions but only from 3/302 (1%) samples postintervention. This 
suggests that the postintervention methods used are effective on the destruction of 
MAP. Thus it could be that at a slaughter plant, well executed processing of the carcass 
might prevent humans from being extensively exposed to MAP through meat. Many 
studies have included lymph nodes in the samples because they are often used in ground 
beef. 
 
In addition to beef, MAP has also been found in goat meat. Manning et al. (2003) 
cultured MAP from clinically infected goats’ kidneys and hindlimb muscles from 4/10 
(40%) and from 2/10 (20%) of the samples, respectively. 
 
Klanicova et al. (2011) studied also the occurrence of MAP in cooked pork and chicken 
and they found MAP DNA from 14% of pork samples and from 50% of chicken 
samples. They were not able to culture MAP from any of the samples. Swine and 
poultry don’t have JD so the results suggest contamination of the products in the 
processing phase. Thus it is extremely important that the processing phase of any 
product is done according to good hygiene standards. 
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Table 7  The occurrence of MAP in beef 
     Positive 
samples 
  
Country 
Type of 
cattle 
Disease status Sampling site Detection method No (%) Detection limit Reference 
 
USA beef  
sounda 
liver 
culture (Cornell double 
incubation) 
1/350 (0.3) NDb Rossiter & Henning 2001 
USA beef  
sounda superficial & popliteal 
lymph nodes 
culture (Cornell double 
incubation) 
1/350 (0.3) ND Rossiter & Henning 2001 
USA dairy  
soundc 
liver 
culture (Cornell double 
incubation) 
15/189 (8) ND Rossiter & Henning 2001 
USA dairy  
soundc superficial & popliteal 
lymph nodes 
culture (Cornell double 
incubation) 
6/189 (3) ND Rossiter & Henning 2001 
USA, 
California 
NK NK retail ground beef RT-PCRd (IS900) 0/200 (0) 101 cfu/g Jaravata et al. 2007 
North 
America 
fed  NRe 
carcass swab, anal region, 
after skinning 
nPCRf (IS900, f57, 
IACg) 
43/98 (44) ND Meadus et al. 2008 
North 
America 
beef  NR 
carcass swab, anal region, 
after dressing 
nPCR (IS900, f57, IAC) 24/100 (24) ND Meadus et al. 2008 
USA fed  NR carcass swab culture (HEYAh) 0/455 (0) ND Wells et al. 2009 
USA cull  NR 
carcass swab, 
preevisceration 
culture (HEYA) 
172/338 
(51) 
ND Wells et al. 2009 
USA cull  NR 
carcass swab, 
postintervention 
culture (HEYA) 3/302 (1) ND Wells et al. 2009 
USA fed  NR ileocecal lymph nodes  PCR (IS900) 1/232 (0.4) ND Wells et al. 2009 
USA cull  NR ileocecal lymph nodes  PCR (IS900) 
113/330 
(34) 
ND Wells et al. 2009 
USA fed  NR hides PCR (IS900) 3/243 (1) ND Wells et al. 2009 
USA cull  NR hides PCR (IS900) 
273/343 
(80) 
ND Wells et al. 2009 
USA, 
California 
dairy  
disseminated 
infectioni 
muscle (longissimus colli, 
extensor carpi radialis),  
culture (HEYMj) 0/21 (0) ND Antognoli et al. 2008 
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Table 7  Continued 
     Positive 
samples 
  
Country 
Type of 
cattle 
Disease status Sampling site Detection method 
No (%) 
 
 
Detection limit Reference 
USA, 
California 
dairy  
disseminated 
infection 
liver culture (HEYM) 10/21 (48) ND Antognoli et al. 2008 
USA, 
California 
dairy  
disseminated 
infection 
kidney culture (HEYM) 6/21 (29) ND Antognoli et al. 2008 
Spain 
dairy and 
beefk 
infected herds muscle, diaphragm culture (HEYM, LJMl) 6/47 (13) ND Alonso-Hearn et al. 2009m 
Spain 
dairy and 
beefk 
infected herds mesenteric lymph nodes culture ( HEYM, LJM) 23/47 (49) ND Alonso-Hearn et al. 2009m 
Canada dairy 
clinically 
infected 
liver, lymph nodes,  
culture (HEYA, 
MGITn) 
7/15 (47) 4 cfu Mutharia et al.2009 
Canada dairy 
clinically 
infected 
kidneys, lymph nodes  culture (HEYA, MGIT) 5/15 (33) 1 cfu Mutharia et al.2009 
Australia NR 
clinically 
infected 
muscle (rump, 
forequarter) 
culture (BACTECo) 1/9 (11) 
1.77 ± 0.4 log10  
organisms per gram 
of meat 
Reddacliff et al. 2010p 
Australia NR 
clinically 
infected 
lymph nodes culture (BACTEC) 5/9 (55) 
1.77 ± 0.4 
log10organisms per 
gram of meat 
Reddacliff et al. 2010p 
a
Body score <4 (1−9)  
b
ND No detection limit was identified
  
cBody score <2.5 (1−5)  
d
RT-PCR Real-Time PCR 
e
NR Not reported 
f
nPCR Nested PCR
 
 
g
IAC – internal amplification control 
h
HEYA Herrold Egg Yolk Agar 
i
Disseminated infection determined as MAP isolated in 
tissues other than intestine and associated lymph nodes 
 
j
HEYM Herrold Egg Yolk Medium 
k
Forty-two dairy cows, five beef cows 
l
LJM Löwenstein-Jensen medium 
m
26% of the animals had clinical signs of JD 
n
MGIT Mycobacteria Growth Indicator Tube 
o
BACTEC Radiometric Culture 
p
Acid-pepsin digestion technique used as a  
decontamination method
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Table 8  The occurrence of MAP in mutton 
    Positive 
samples 
  
Country Disease status Sampling site Detection method No (%) Detection limit Reference 
Australia 
uninfected 
animals 
supramammary lymph 
nodes, uterus;  
culture (BACTECa) 4/136 (3) NDb Lambeth et al. 2004 
Australia 
subclinical 
infection 
muscle (rump, 
forequarter),  
culture (BACTEC) 1/22 (5) 
1.77 ± 0.4 
log10organisms per 
gram of meat 
Reddacliff et al. 2010c 
Australia 
subclinical 
infection 
peripheral lymph nodes culture (BACTEC) 7/22 (32) 
1.77 ± 0.4 
log10organisms per 
gram of meat 
Reddacliff et al. 2010c 
New 
Zealand 
subclinical 
infection 
muscle, biceps femoris culture (BACTEC) 4/30 (13) ND Smith et al. 2011 
Australia 
heavily infected 
herd 
fetusd,e culture (BACTEC) 2/119 (2) ND Lambeth et al. 2004 
Australia clinical cases mammary gland,  culture (BACTEC) 2/136 (1) ND Lambeth et al. 2004 
Australia 
clinically 
infected 
muscle (rump, 
forequarter),  
culture (BACTEC) 20/34 (59) 
1.77 ± 0.4 
log10organisms per 
gram of meat 
Reddacliff et al. 2010c 
Australia 
clinically 
infected 
peripheral lymph nodes,  culture (BACTEC) 29/34 (85) 
1.77 ± 0.4 
log10organisms per 
gram of meat 
Reddacliff et al. 2010c 
Australia infected herd mesenteric lymph nodes culture (BACTEC) 44/46 (96) ND Dennis et al. 2011 
New 
Zealand 
clinically 
infected 
muscle, biceps femoris,  culture (BACTEC) 5/21 (24) ND 
 
Smith et al. 2011 
a
BACTEC Radiometric Culture 
b
ND No detection limit was identified 
c
Acid-pepsin digestion technique used as a decontamination method
 
d
Both positive samples were from ewes with clinical signs 
e
Samples from liver, spleen, umbilicus 
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The occurrence of MAP in plants has only been studied in one study. In the study, 
Pribylova et al. (2011) used a field with deliberately exposed to MAP infected mouflon 
feces. The feces were deposited on the field by the animals themselves and the plants 
were examined 15 weeks after exposure to the feces (Pribylova et al. 2011). MAP was 
not cultured on the plant parts but IS900 sequence was detected in 13/19 (68%) of green 
upper parts of the plants and in 15/19 (79%) of the roots of the plants (Pribylova et al. 
2011). 
 
MAC is often found in drinking water systems but Table 8 only represents MAP found 
in drinking water and drinking water systems. From Table 8, it is easy to notice that 
MAP DNA is frequently found in raw surface water but also from drinking water 
systems and tap water. It seems to survive well of the normal drinking water treatments. 
Mishina et al. (1996) cultured from municipal water supply from a major city in the 
United States for the first time in 1996. The study didn’t specify the name of the city in 
question. In addition, only 2 other studies had positive results on culture of MAP. That 
might be due to the difficultness of culturing MAP or that viable MAP are not present in 
drinking water at such numbers as MAP DNA. Also the sensitivity of PCR is greater 
than that of culture method.  
Table 9 The occurrence of MAP in water and drinking water systems 
   Positive 
samples 
  
Country Sample 
Detection 
method 
No (%) 
 
 
Detection 
limit 
Reference 
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a
NA Not available 
bMAP was cultured but the study didn’t specify 
exact numbers 
c
ND No detection limit was identified 
d
qPCR Quantitative PCR 
e
BACTEC Radiometric culture 
f
HEYM Herrold Egg Yolk Medium 
g
IMS-PCR Immunomagnetic separation 
combined with PCR 
h
f57 was tested only on IS900 positive samples 
i
snPCR Seminested PCR 
j
nPCR Nested PCR
USA 
municipal water 
supply 
culture NAa,b (NA) NDc Mishina et al. 1996 
UK river water culture 12/96 (13) ND Pickup et al. 2005 
UK river water qPCRd(IS900) 31/96 (32) ND Pickup et al. 2005 
Northern 
Ireland 
water treatment 
plant 
culture 
(BACTECe or 
HEYMf) 
8/192 (4) ND Whan et al. 2005 
Northern 
Ireland 
water treatment 
plant 
IMS-PCRg 
(IS900) 
9/192 (5) ND Whan et al. 2005 
UK river water PCR (IS900) 48/70 (69) ND Pickup et al. 2006 
UK 
household cold 
water tank 
sediment 
PCR (IS900) 1/54 (2) ND Pickup et al. 2006 
UK 
finished drinking 
water 
100 liters 
PCR (IS900) 0/1 (0) ND Pickup et al. 2006 
USA, 25 
states 
drinking water qPCR (IS900) 5/238 (0.02) ND Beumer et al. 2010 
USA, 
Midwest 
drinking water 
qPCR (IS900 and 
target 251) 
29/33 (88) ND Beumer et al. 2010 
USA, 
Midwest 
faucet biofilm 
qPCR (IS900 and 
target 251) 
25/33 (76) ND Beumer et al. 2010 
Northern 
Ireland 
raw surface water PCR (IS900) 27/48 (56) 10 cfu/ml Aboagye et al. 2011 
Northern 
Ireland 
raw surface water PCR (f57)h 7/27 (26) 103 cfu/ml Aboagye et al. 2011 
Northern 
Ireland 
treated water PCR (IS900) 20/43 (47) 10 cfu/ml Aboagye et al. 2011 
Northern 
Ireland 
treated water PCR (f57)h 1/20 (5) 103 cfu/ml Aboagye et al. 2011 
Northern 
Ireland 
treated water 
culture 
(BACTEC) 
1/NA (NA) 30 cfu/plate Aboagye et al. 2011 
Italy drinking water 
snPCRi & nPCRj 
(f57 & IS900) 
3/90 (3) ND Pistone et al. 2012 
India river water 
microscopic 
examination 
6/20 (30) ND Singh et al. 2012 
India river water PCR (IS900) 2/20 (10) ND Singh et al. 2012 
the Czech 
Republic 
reservoir sediment 
Duplex qPCR 
(IS900) 
36/52 (69) 102 copies/g Klanicova et al. 2013 
the Czech 
Republic 
water treatment 
sludge 
Duplex qPCR 
(IS900) 
7/34 (21) 102 copies/g Klanicova et al. 2013 
the Czech 
Republic 
household 
sediment 
Duplex qPCR 
(IS900) 
2/38 (5) 102 copies/g Klanicova et al. 2013 
UK river Douglas qPCR (IS900) ND (42) 
0.1−1 cell 
equivalents 
Rhodes et al. 2013 
UK river Wyre qPCR (IS900) ND (36) 
0.1−1 cell 
equivalents 
Rhodes et al. 2013 
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12 ORIGIN, CONSUMPTION AND IMPORT OF FOOD IN FINLAND 
12.1 Origin of food 
12.1.1 Import of cattle 
In 2012, 46 live cattle were imported to Finland. Of those 33 cattle were from Sweden, 
three from Denmark and ten from Scotland (ETT 2014a). 
 
12.1.2 Drinking water 
In Finland, 42% of drinking water comes from surface water and 58% from 
groundwater and artificial groundwater (Hänninen 2007). Drinking water in the 
Helsinki metropolitan area (cities of Helsinki, Vantaa, Espoo, Kauniainen) to 1.2 
million people, is taken from Lake Päijänne (HSY 2014b). Also small amounts of 
ground water and water from Lake Pitkäjärvi are used in the Helsinki metropolitan area 
(HSY 2014b). 
 
12.2 Consumption and import of food 
12.2.1 Consumption of food 
The figures for the annual consumption of foods and the share and amount of imported 
food of all consumed in Finland in 2012 per capita are represented in Table 10. The 
figures are calculated based on the production statistics presented in the Balance sheet 
for food commodities 2012, from the Information Centre of the Ministry of Agriculture 
and Forestry, Tike (Tike 2014c). The consumption of lamb and mutton, goat meat and 
goat cheese are not represented due to the low consumption (< 0.5 kg per capita 
annually). Also the consumption of vegetables is not represented because the lack of 
evidence of the occurrence of MAP in this food group. 
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a
NA Not available  
 
The consumption of imported beef and veal is rising in Finland because Finnish cattle 
production is diminishing every year (Table 10, Tike 2014a). The annual production has 
decreased about 15 million kg in ten years, from almost 96 million kg in 2003 to 81 
million kg in 2013 (Tike 2014a). The consumption of beef on the other hand has stayed 
around 18−19 kg per capita annually (Tike 2014d). For example, in 2010 the amount of 
imported beef and veal of all consumed was 2.3 kg per capita so it has almost doubled 
in just two years (Tike 2014a,b). The share of imported cheese of all cheese consumed 
is also rising, from 8.9 kg per capita in 2010 to 11.3 kg per capita in 2012 (Table 10, 
Tike 2014c). This is explained both by the increase in consumption of cheese and by 
increase in import of cheese to Finland (Tike 2014c,d). 
 
12.2.2 Import of food 
In 2102, beef was mostly imported from Poland, the Netherlands, Germany and 
Denmark (Uljas 2014). Over 51 million kilograms of milk and cream were imported to 
Finland from Sweden in 2012 representing 77 % of all imported milk that year (Uljas 
2014). The rest was mostly imported from Germany and Estonia (Uljas 2014). Cheese 
Table 10 Annual consumption per capita of selected food groups and share of imported 
food of all consumed food in Finland in 2012 
Product 
Annual 
consumption 
per capita, kg 
Imported 
food of all 
consumed, kg 
(%) 
Reference 
Beef and veal (inc. 
home slaughter) 
18.7 4.0 (21.6) Tike 2014c,d 
Liquid dairy (incl. 
cream, curdled 
milk, sour milk) 
159.2 12.3 (7.7) Tike 2014d, Uljas 2014 
Raw milk 1.7 NA
a
 Tike 2014c 
Cheese 21.9 11.3 (51.6) Tike 2014c,d 
Yogurt 23.3 6.5 (27.9) Tike 2014c,d 
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was imported from Germany, Denmark and Sweden (Uljas 2014). The biggest yogurt 
importing countries in 2012 were Germany, Poland and Estonia (Uljas 2014).  
 
13 ORIGIN, CONSUMPTION AND IMPORT OF FOOD IN THE UNITED STATES  
13.1 Origin of drinking water 
In the United States, 80% of all water used comes from surface water and 20% from 
groundwater (Barber 2005). In Minnesota, over 70% of the drinking water consumed is 
groundwater (Water System Council 2014). Drinking water in Minneapolis comes from 
the Mississippi River (City of Minneapolis 2014a). 
 
13.2 Consumption and import of food 
13.2.1 Consumption of food 
There are no statistics about the consumption of raw milk in the United States. In a 
survey made by the Centers for Disease Control over 17,000 people in 10 states were 
asked about their food consumption (CDC 2006–2007). Of these people, 3% answered 
that they had drunk unpasteurized (raw) milk during the past seven days. The 
percentage was 2% in Minnesota (CDC 2006–2007). In Minnesota, consumers are 
occasionally allowed to buy unpasteurized, raw cow’s, goat’s or sheep’s milk for 
personal use from the place or farm where the milk is produced (Minnesota Statutes 
2013). 
The figures for the annual consumption of foods in the United States per capita in 2009 
are represented in Table 11.  
Table 11 Annual consumption of foods in the United States per capita in 2011 
Beef, kg 
Liquid 
dairy 
products, 
kg 
Cheese, kg Yogurt, kg Reference 
26.0 84.5 15.0 6.2
 USDA − ERS 2014a,b,c 
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13.2.2 Import of beef and veal 
The biggest beef and veal importing countries in the US are Australia, Canada, New 
Zealand and Brazil (USDA – ERS 2014d). For example in Australia JD is present in 
dairy herds the southern part of the country including Tasmania but they have 
implemented an effective control program to prevent the spread of the disease between 
states and between dairy and cattle herds (Animal Health Australia 2014). The share of 
imported beef and veal of the total beef supply in the US was about 9% in 2012 (USDA 
– ERS 2014d). Of all imported beef and veal, about 30% came from Australia in 2012 
(USDA – ERS 2014d). 
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14 DISCUSSION 
 
There are several uncertainties about the etiology of CD. The possible role of MAP in 
the development of the disease has been suggested already over 100 years ago but the 
association between MAP and CD is difficult to prove reliably. MAP is widely present 
in the environment; therefore humans are exposed to the bacterium for example through 
food and drinking water and by occupational exposure. MAP is also found in CD 
patients’ tissues more often than from healthy controls’ tissues. At the moment it is not 
known whether MAP is just a commensal bacterium in the gut of humans or indeed a 
human pathogen. It could be possible that subgroups of patients with different 
genotypes are more susceptible to some etiological agents of CD than others and 
therefore not only one type of disease could exist. Also, if MAP was a pathogenic 
bacterium to humans, the infective dose of the bacterium would be unknown.  
 
MAP is very durable in the environment and it can survive standard pasteurization 
methods. It is thus possible that MAP could be one of the etiological agents of CD but 
controversy exists. MAP is frequently found in food and drinking water and the 
exposure to MAP can be estimated but it is still unknown if MAP present in food is able 
to infect people. The detection of MAP from food is more common by PCR than by 
culture in dairy products. PCR detects MAP DNA, therefore both dead and viable MAP 
are found. It is unknown if also MAP DNA from dead cells is able to elicit 
inflammation in humans.  
 
JD is a globally important disease of cattle and other ruminants and it causes massive 
economic impacts to the cattle industry throughout the world. The prevalence of JD in 
cattle is low in only few places in the world as in the Nordic countries. In general, the 
prevalence of JD is high in the United States. Studies conducted on national level have 
found the prevalence of JD to be much lower in beef cattle than in dairy cattle. Beef 
cattle are sent to slaughter before two years of age. The incubation period of JD is very 
long and thus it is rare that beef cattle present clinical signs of JD while being raised at 
the farm. Sensitivity of ELISA has been found to be only about 15% to detect 
subclinical cases of JD. That is why the true prevalence of JD in beef cattle is 
presumably much higher than the apparent prevalence. The prevalence of JD in dairy 
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cattle is higher on national level than in Minnesota but still about half of all Minnesotan 
dairy herds are positive for JD. 
 
In Finland the situation is completely different since only few positive cases of JD in 
beef cattle have been found in Finland since the beginning of the 90’s. No positive cases 
in dairy cattle have been found. Since the disease is so rare, it might be possible that 
veterinarians don’t include the disease on their differential list of diseases when 
diagnosing cattle with emaciation and diarrhea. Also dairy cows are sent to slaughter at 
a fairly young age in Finland so seeing a clinical case of JD in dairy cows would be a 
rare occasion. Thus it might be possible that the true prevalence of JD is higher than 
previously thought in Finland but the importance of the disease is still quite small. 
Import of cattle to Finland is low and majority of live cattle imported are from Sweden 
where the prevalence of JD is equally low as in Finland. Also the import requirements 
are quite tight. Therefore the odds of that the disease would spread to Finland through 
imported animals seems to be minimal. 
 
The occurrence of MAP in drinking water has not been studied in Finland. It is not 
likely that Finnish people are exposed to MAP through drinking water due to the low 
prevalence of JD in the country. Finnish people eat mostly food of Finnish origin but in 
some food groups the proportion of imported food is high, such as in cheese, yogurt and 
beef. The prevalence of JD in the biggest importing countries, such as in Germany and 
Denmark is very high. Therefore it is likely that Finns who eat a lot of imported food  in 
these food groups are exposed to the bacterium in a much larger scale compared to 
Finns only eating food of Finnish origin or only a little of imported food. Even though 
Finland is quite self-sufficient in many food products such as liquid milk; new 
processed foods, such as functional food are becoming more and more popular among 
consumers. This might create new needs importing more food in these food groups. 
Also the import of food in certain food groups is rising. These facts might also increase 
the exposure of Finnish people to MAP. Nevertheless, based on this literature review it 
can be noted that the exposure of humans to MAP in Finland through food and drinking 
water is low. 
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Viable MAP have been found in drinking water in the United States. The source of 
drinking water in the country varies a lot but in Minnesota 30% of the drinking water 
comes from surface water. There is a bigger risk that surface water contains more MAP 
than groundwater since the surface water is not purified naturally when it goes through 
the layers of the ground like groundwater does. Runoffs from farms can get into 
drinking water. There are a lot of dairy and beef farms in Minnesota and runoffs from 
these farms can result in contamination of surface water resources. Because the 
prevalence of JD is so high in the state, it is possible that MAP is present in drinking 
water in Minnesota and that people are exposed to the bacterium. Drinking water from 
surface sources in the United States is chlorinated but the effectiveness of chlorination 
regarding killing MAP has been found to be ineffective.  
 
The share of imported beef is less than 10% in the United States. Even though about one 
third of beef is imported from Australia where JD is not endemic in the whole country, 
the large majority of beef consumed in the United States is produced there and therefore 
it is likely that people eating beef in the United States are exposed to MAP. The 
exposure to MAP can be limited or prevented though if the slaughtering process is 
executed with high hygiene standards and meat is cooked and handled correctly at 
home. In Minnesota, the exposure of humans to MAP through food is at least moderate 
because the prevalence of JD is quite high and the consumption of foods that are proven 
to contain MAP such as liquid dairy products is quite high. Based on this thesis it can be 
stated that people in Minnesota are exposed to MAP through food and drinking water in 
a much larger scale than Finnish people since the prevalence of JD in Minnesota and in 
the United States is so high. 
 
The prevalence and incidence of CD have been increasing globally in the past 70 years. 
The reasons for this are unknown but possible explanations are actual increase of 
incidence and the ever more developing diagnostic methods of medicine. The 
prevalence of CD is higher in Minnesota than in Finland in adult patients. Regardless of 
this, the prevalence of CD in Finland is also among the highest reported in the world. 
CD has been studied more in Minnesota than in Finland and this might partly may 
explain the differences. Finland and Minnesota are situated on different latitudes and 
they both share a fairly similar climate. They both have a population of about 5 million 
and they both have high proportion of white inhabitants and high level of education. In 
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the late 19
th
 century and early 20
th
 century a large number of Finns immigrated to 
Minnesota. The similar demographic and climatic characteristics of Minnesota and 
Finland might explain the high prevalence of CD in these geographical areas if they 
shared environmental factors that have an impact in the development of CD. But that 
kind of geographical comparison has not been done and it is not known if this 
hypothesis is true. 
 
The prevalence of JD is very high in some European countries such as Germany and 
Denmark but the prevalence and incidence of CD is about the same in these countries 
and Finland. If MAP was an etiological agent of CD, it would be intriguing to discover 
the pathogenesis of CD in Finnish patients because of the low exposure of Finnish 
people to MAP compared to many other countries. What would be the reason of the 
high prevalence of CD in Finland if it wasn’t MAP? 
 
 
15 CONCLUSIONS  
 
This thesis supports the hypothesis that people in areas of high prevalence of JD are 
exposed more to MAP than people in areas of low prevalence of JD. Based on this 
literature review it can be assumed that in Finland CD would be caused by some other 
environmental agent than MAP. To prove this statement, further research is required. 
The prevalence of JD in Finland has to be studied with larger scale studies than 
previously done. Also the occurrence of MAP in Finnish foods has to be studied. 
 
This kind of literature review has not been done previously. Comparing subsets of CD 
patients with high exposure to MAP to controls with and without of human exposure to 
MAP through food and drinking water could help reveal the possible role of MAP in the 
complex etiology of CD. This thesis sets up further research needed to be done in 
estimating the true exposure of humans to MAP in geographic areas with different 
prevalence of JD.  
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